Guidelines for the welfare and use of animals in cancer research

Paul Workman(Institute of Cancer Research), Eric O. Aboagye(Imperial College London), Frances R. Balkwill(Queen Mary University of London), Allan Balmain(University of California, San Francisco), Greg Bruder(University of Manchester), D J Chaplin, J A Double(University of Bradford), Jeffrey I. Everitt(Research Triangle Park Foundation), David Farningham(University of Cambridge), M J Glennie(Southampton General Hospital), Lloyd R. Kèlland(University College London), Vicky Robinson(National Centre for the Replacement Refinement and Reduction of Animals in Research), Ian J. Stratford(University of Manchester), Gillian M. Tozer(University of Sheffield), Sue‐Ann Watson(Queen's Medical Centre), Stephen R. Wedge(AstraZeneca (United Kingdom)), Sue Eccles(Institute of Cancer Research)
British Journal of Cancer
May 1, 2010
Cited by 1,440Open Access
Full Text

Abstract

Animal experiments remain essential to understand the fundamental mechanisms underpinning malignancy and to discover improved methods to prevent, diagnose and treat cancer. Excellent standards of animal care are fully consistent with the conduct of high quality cancer research. Here we provide updated guidelines on the welfare and use of animals in cancer research. All experiments should incorporate the 3Rs: replacement, reduction and refinement. Focusing on animal welfare, we present recommendations on all aspects of cancer research, including: study design, statistics and pilot studies; choice of tumour models (e.g., genetically engineered, orthotopic and metastatic); therapy (including drugs and radiation); imaging (covering techniques, anaesthesia and restraint); humane endpoints (including tumour burden and site); and publication of best practice.


Related Papers

No related papers found

Powered by citation graph analysis